A case of Wernicke's encephalopathy following fluorouracil-based chemotherapy.
The pyrimidine antimetabolite 5-fluorouracil (5-FU) is a chemotherapeutic agent used widely for various tumors. Common side effects of 5-FU are related to its effects on the bone marrow and gastrointestinal epithelium. Neurotoxicity caused by 5-FU is uncommon, although acute and delayed forms have been reported. Wernicke's encephalopathy is an acute, neuropsychiatric syndrome resulting from thiamine deficiency, and has significant morbidity and mortality. Central nervous system neurotoxicity such as Wernicke's encephalopathy following chemotherapy with 5-FU has been reported rarely, although it has been suggested that 5-FU can produce adverse neurological effects by causing thiamine deficiency. We report a patient with Wernicke's encephalopathy, reversible with thiamine therapy, associated with 5-FU-based chemotherapy.
Cho
In Jeong
IJ
Division of Hematology-Oncology, Department of Internal Medicine, School of Medicine, Ewha Womans University, Seoul, Korea.
Chang
Hye Jung
HJ
Lee
Kyoung Eun
KE
Won
Hye Sung
HS
Choi
Moon Young
MY
Nam
Eun Mi
EM
Mun
Yeung-Chul
YC
Lee
Soon Nam
SN
Seong
Chu-Myong
CM
D000208:Acute Disease; D000964:Antimetabolites, Antineoplastic / Q000009:adverse effects*; D005260:Female; D005472:Fluorouracil / Q000009:adverse effects*; D006801:Humans; D008279:Magnetic Resonance Imaging; D008875:Middle Aged; D009303:Nasopharyngeal Neoplasms / Q000188:drug therapy / Q000532:radiotherapy; D013831:Thiamine / Q000627:therapeutic use; D013832:Thiamine Deficiency / Q000150:complications* / Q000175:diagnosis; D014899:Wernicke Encephalopathy / Q000139:chemically induced* / Q000175:diagnosis
D000964:Antimetabolites, Antineoplastic; D005472:Fluorouracil; D013831:Thiamine